Michela Tarnani

814 total citations
26 papers, 552 citations indexed

About

Michela Tarnani is a scholar working on Genetics, Pathology and Forensic Medicine and Hematology. According to data from OpenAlex, Michela Tarnani has authored 26 papers receiving a total of 552 indexed citations (citations by other indexed papers that have themselves been cited), including 21 papers in Genetics, 15 papers in Pathology and Forensic Medicine and 9 papers in Hematology. Recurrent topics in Michela Tarnani's work include Chronic Lymphocytic Leukemia Research (20 papers), Lymphoma Diagnosis and Treatment (14 papers) and Immunodeficiency and Autoimmune Disorders (8 papers). Michela Tarnani is often cited by papers focused on Chronic Lymphocytic Leukemia Research (20 papers), Lymphoma Diagnosis and Treatment (14 papers) and Immunodeficiency and Autoimmune Disorders (8 papers). Michela Tarnani collaborates with scholars based in Italy, Japan and United States. Michela Tarnani's co-authors include Luca Laurenti, Giovanni D’Arena, Giuseppe Leone, Simona Sica, Dimitar G. Efremov, Silvia Deaglio, Patrizia Chiusolo, Nicola Cascavilla, Laura De Martino and Lisa Bonello and has published in prestigious journals such as Journal of Clinical Oncology, Blood and Leukemia.

In The Last Decade

Michela Tarnani

24 papers receiving 544 citations

Peers

Countries citing papers authored by Michela Tarnani

Since Specialization

Citations

This map shows the geographic impact of Michela Tarnani's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michela Tarnani with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michela Tarnani more than expected).

Fields of papers citing papers by Michela Tarnani

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Michela Tarnani. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michela Tarnani. The network helps show where Michela Tarnani may publish in the future.

Co-authorship network of co-authors of Michela Tarnani

This figure shows the co-authorship network connecting the top 25 collaborators of Michela Tarnani. A scholar is included among the top collaborators of Michela Tarnani based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Michela Tarnani. Michela Tarnani is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Spleen Involvement at Diagnosis of Multiple Myeloma: A Case Report and Literature Review 2025 ·Cancer Reports ·Alessia Fiorini, (unknown), (unknown), Marco Dell’Aquila, (unknown), Daniele Remotti, Michela Tarnani, Marco Montanaro, Roberto Latagliata, Alessandro Andriani	0
2	Treatment Sequencing and Outcome of Chronic Lymphocytic Leukemia Patients Treated at Fondazione Policlinico Universitario Agostino Gemelli IRCCS: A Thirty-Year Single-Center Experience 2023 ·Cancers ·Idanna Innocenti, (unknown), (unknown), Michela Tarnani, (unknown), (unknown), (unknown), Eugenio Galli, (unknown), Diana Giannarelli, Francesco Autore, Luca Laurenti	2
3	New and Old Monoclonal Antibodies for the Treatment of Chronic Lymphocytic Leukemia 2011 ·Mini-Reviews in Medicinal Chemistry ·Luca Laurenti, (unknown), (unknown), (unknown), (unknown), Barbara Vannata, Idanna Innocenti, Michela Tarnani, Silvia Deaglio, Simona Sica, Dimitar G. Efremov, Giuseppe Leone	3
4	Intralesional administration of rituximab for treatment of CD20 positive orbital lymphoma: Safety and efficacy evaluation 2011 ·Leukemia Research ·Luca Laurenti, (unknown), (unknown), Michela Tarnani, Simona Sica, Maria Antonietta Blasi, Gustavo Savino, Giuseppe Leone	21
5	The coexistence of chronic lymphocytic leukemia and myeloproliperative neoplasms: A retrospective multicentric GIMEMA experience 2011 ·American Journal of Hematology ·Luca Laurenti, Michela Tarnani, Ilaria Nichele, Stefania Ciolli, Agostino Cortelezzi, Francesco Forconi, Davide Rossi, Francesca Romana Mauro, Giovanni D’Arena, Giovanni Del Poeta, Marco Montanaro, Fortunato Morabito, Caterina Musolino, Vincenzo Callea, Lorenzo Falchi, Alessandra Tedeschi, Achille Ambrosetti, Gianluca Gaïdano, Giuseppe Leone, Robin Foà	37
6	Low-Dose Valganciclovir as Preemptive Therapy for Cytomegalovirus Infection Occurring in Allogeneic Stem Cell Transplant Recipients 2010 ·Acta Haematologica ·Mariangela Palladino, Luca Laurenti, Patrizia Chiusolo, (unknown), Idanna Innocenti, Michela Tarnani, Federica Sorà, Simona Sica, Giuseppe Leone	9
7	Reduced expression of the tumor suppressor PHLPP1 enhances the antiapoptotic B-cell receptor signal in chronic lymphocytic leukemia B-cells 2010 ·Leukemia ·(unknown), Luca Laurenti, Michela Tarnani, (unknown), Sami N. Malek, Dimitar G. Efremov	23
8	Light chain deposition in peripheral nerve as a cause of mononeuritis multiplex in Waldenström's macroglobulinaemia 2010 ·Journal of the Neurological Sciences ·Marco Luigetti, Giovanni Frisullo, Luca Laurenti, Amelia Conte, Francesca Madia, Paolo Profice, A. P. Batocchi, Nicola Montano, Michela Tarnani, P. Tonali, Mario Sabatelli	15
9	Comparison between oral and intravenous fludarabine plus cyclophosphamide regime as front-line therapy in patients affected by chronic lymphocytic leukaemia: influence of biological parameters on the clinical outcome 2010 ·Annals of Hematology ·Luca Laurenti, (unknown), Michela Tarnani, Nicola Piccirillo, Paolo Falcucci, Giovanni D’Arena, Idanna Innocenti, Sara Marietti, Dimitar G. Efremov, Patrizia Chiusolo, Gina Zini, Federica Sorà, Simona Sica, Giuseppe Leone	10
10	ALLOGENEIC TRANSPLANTATION FOR CHRONIC LYMPHOCYTIC LEUKEMIA 2010 ·Mediterranean Journal of Hematology and Infectious Diseases ·Luca Laurenti, Michela Tarnani, Patrizia Chiusolo, Federica Sorà, Simona Sica	2
11	Chronic lymphocytic leukemia‐associated immune thrombocytopenia treated with rituximab: a retrospective study of 21 patients 2010 ·European Journal Of Haematology ·Giovanni D’Arena, Silvana Capalbo, Luca Laurenti, Giovanni Del Poeta, Giuseppe Nunziata, Silvia Deaglio, (unknown), Michela Tarnani, (unknown), Catello Califano, Felicetto Ferrara, Nicola Cascavilla	22
12	Multicentre validation of a prognostic index for overall survival in chronic lymphocytic leukaemia 2010 ·Hematological Oncology ·Pietro Bulian, Michela Tarnani, Davide Rossi, Francesco Forconi, Giovanni Del Poeta, Francesco Bertoni, Emanuele Zucca, Marco Montillo, Gabriele Pozzato, Silvia Deaglio, Giovanni D’Arena, Dimitar G. Efremov, Roberto Marasca, Francesco Lauria, Valter Gattei, Gianluca Gaïdano, Luca Laurenti	21
13	Oral fludarabine and cyclophosphamide as front-line chemotherapy in patients with chronic lymphocytic leukemia. The impact of biological parameters in the response duration 2008 ·Annals of Hematology ·Luca Laurenti, Michela Tarnani, (unknown), Dimitar G. Efremov, Gina Zini, Mariagrazia Garzia, Nicola Piccirillo, Patrizia Chiusolo, Federica Sorà, Idanna Innocenti, Simona Sica, Giuseppe Leone	10
14	Early diagnosis followed by front-line autologous peripheral blood stem cell transplantation for patients affected by POEMS syndrome 2008 ·Leukemia Research ·Luca Laurenti, Silvia De Matteis, Mario Sabatelli, Amelia Conte, Patrizia Chiusolo, Federica Sorà, Nicola Piccirillo, Tommaso Zà, Michela Tarnani, Elena Rossi, Giuseppe Leone, Simona Sica	24
15	Prognostic significance of combined analysis of ZAP‐70 and CD38 in chronic lymphocytic leukemia 2007 ·American Journal of Hematology ·Giovanni D’Arena, Michela Tarnani, Carlo Rumi, Tiziana Vaisitti, Semra Aydin, Rosaria De Filippi, Federica Perrone, Antonio Pinto, Patrizia Chiusolo, Silvia Deaglio, Fabio Malavasi, Luca Laurenti	33
16	Low incidence of secondary neoplasia after autotransplantation for lymphoproliferative disease: the role of pre‐transplant therapy 2007 ·Clinical Transplantation ·Luca Laurenti, Michela Tarnani, Patrizia Chiusolo, Giuseppe La Torre, Mariagrazia Garzia, Marcella Zollino, Gina Zini, M. Balducci, Giuseppe Leone, Simona Sica	5
17	Low-dose thalidomide in combination with oral fludarabine and cyclophosphamide is ineffective in heavily pre-treated patients with chronic lymphocytic leukemia 2006 ·Leukemia Research ·Luca Laurenti, (unknown), Michela Tarnani, (unknown), Mariagrazia Garzia, Dimitar G. Efremov, Nicola Piccirillo, Patrizia Chiusolo, Simona Sica, Giuseppe Leone	16
18	Rituximab therapy for chronic lymphocytic leukemia-associated autoimmune hemolytic anemia 2006 ·American Journal of Hematology ·Giovanni D’Arena, Luca Laurenti, Silvana Capalbo, Alfonso Maria D’Arco, Rosaria De Filippi, Gianpaolo Marcacci, Nicola Di Renzo, Sergio Storti, Catello Califano, Maria Luigia Vigliotti, Michela Tarnani, Felicetto Ferrara, Antonio Pinto	77
19	Comparison of ZAP-70/Syk mRNA levels with immunoglobulin heavy-chain gene mutation status and disease progression in chronic lymphocytic leukemia. 2005 ·PubMed ·Luca Laurenti, Aleksandar Petlickovski, Carlo Rumi, Stefania Gobessi, (unknown), Michela Tarnani, (unknown), Sara Marietti, Simona Sica, Giuseppe Leone, Dimitar G. Efremov	17
20	Cytomegalovirus reactivation during alemtuzumab therapy for chronic lymphocytic leukemia: incidence and treatment with oral ganciclovir. 2004 ·PubMed ·Luca Laurenti, (unknown), Paola Cattani, Antonella Cingolani, Dimitar G. Efremov, Patrizia Chiusolo, Michela Tarnani, Giovanni Maria Fadda, Simona Sica, Giuseppe Leone	53

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact